Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I – II Trial: Complete Statistical AnalysisIndependent statistical analysis of Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NAVIGATE-ADIndependent statistical analysis of A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Navigating Mental Health Treatment for Black Youth: Complete Statistical AnalysisIndependent statistical analysis of Navigating Mental Health Treatment for Black Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05334381).
- NavigatorIndependent statistical analysis of A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3…
- Navigator II Continuous Glucose Monitor Home Use Study: Complete Statistical AnalysisIndependent statistical analysis of Navigator II Continuous Glucose Monitor Home Use Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01455064).
- NAVIOIndependent statistical analysis of A Retrospective Study of the Navio Robotic-assisted Surgical System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03072459).
- Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- NB-001 in Children and Adolescents With 22q11 Deletion Syndrome: Complete Statistical AnalysisIndependent statistical analysis of NB-001 in Children and Adolescents With 22q11 Deletion Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05290493).
- NBI to Detect Post-RT Mucosal Residual NPC: Complete Statistical AnalysisIndependent statistical analysis of NBI to Detect Post-RT Mucosal Residual NPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02584790).
- NC_NEXUSIndependent statistical analysis of North Carolina Newborn Exome Sequencing for Universal Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02826694).
- NCGENES2Independent statistical analysis of North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03548779).
- NCT01009034Independent statistical analysis of Concentrations of Maraviroc in the Semen of HIV-Infected Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01009034).
- NDV-HXP-S Vaccine Clinical Trial (COVIVAC): Complete Statistical AnalysisIndependent statistical analysis of NDV-HXP-S Vaccine Clinical Trial (COVIVAC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05940194).
- NEARIndependent statistical analysis of A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Near Infrared Fluorescence Imaging for Bladder Cancer Detection: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Fluorescence Imaging for Bladder Cancer Detection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03058705).
- Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00566709).
- Near Infrared Spectroscopy Cortical Response to Noxious and Auditory Stimuli in Subjects Under General Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Spectroscopy Cortical Response to Noxious and Auditory Stimuli in Subjects Under General Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NEAR-2Independent statistical analysis of An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- nebhctzIndependent statistical analysis of Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02710071).
- Nebulized Hypertonic Saline for Inpatient Use in COPD: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Hypertonic Saline for Inpatient Use in COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02266875).
- Nebulized Hypertonic Saline for Mechanically Ventilated Children: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Hypertonic Saline for Mechanically Ventilated Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01945944).
- Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nebulized Sub-dissociative Dose Ketamine for Treating Pain: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Sub-dissociative Dose Ketamine for Treating Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03909607).
- Needle Guidance in Ultrasound Guided Nerve Blocks: Complete Statistical AnalysisIndependent statistical analysis of Needle Guidance in Ultrasound Guided Nerve Blocks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080481).
- Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy: Complete Statistical AnalysisIndependent statistical analysis of Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NEEDSIndependent statistical analysis of Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neem Lotion With Combing for Lice: Complete Statistical AnalysisIndependent statistical analysis of Neem Lotion With Combing for Lice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02974088).
- NefigardIndependent statistical analysis of Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Negative Beta Glucan in ICU Patients: Complete Statistical AnalysisIndependent statistical analysis of Negative Beta Glucan in ICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01734525).
- Negative Pressure Wound Therapy-PICO: Cosmesis in Repeat C-Sections: Complete Statistical AnalysisIndependent statistical analysis of Negative Pressure Wound Therapy-PICO: Cosmesis in Repeat C-Sections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05266053).
- Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neo ALTTOIndependent statistical analysis of Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553358).
- Neo TrioIndependent statistical analysis of Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients: Complete Statistical AnalysisIndependent statistical analysis of Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04512430).
- Neo-Synalar Modified 48 Hour Patch Test: Complete Statistical AnalysisIndependent statistical analysis of Neo-Synalar Modified 48 Hour Patch Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02168478).
- Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC): Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263769).
- Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00113230).
- Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors: primary endpoint…
- Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03747120).
- Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00243191).
- Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03237377).
- Neoadjuvant Immunotherapy in Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Immunotherapy in Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04434560).
- Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04869137).